Keurig Dr Pepper price target lowered to $40 from $45 at Barclays

Barclays analyst Lauren Lieberman lowered the firm’s price target on Keurig Dr Pepper to $40 from $45 and keeps an Overweight rating on the shares. The company’s s 2023 outlook includes 5% saes growth and 6%-7% profit growth, the analyst tells investors in a research note.